- Home
- USCB vs SERA Comparison
USCB vs SERA Comparison
Compare USCB & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USCB
- SERA
- Stock Information
- Founded
- USCB 2002
- SERA 2008
- Country
- USCB United States
- SERA United States
- Employees
- USCB N/A
- SERA N/A
- Industry
- USCB Major Banks
- SERA Precision Instruments
- Sector
- USCB Finance
- SERA Health Care
- Exchange
- USCB Nasdaq
- SERA Nasdaq
- Market Cap
- USCB 279.1M
- SERA 258.3M
- IPO Year
- USCB 2021
- SERA 2021
- Fundamental
- Price
- USCB $14.35
- SERA $7.25
- Analyst Decision
- USCB Buy
- SERA
- Analyst Count
- USCB 3
- SERA 0
- Target Price
- USCB $14.83
- SERA N/A
- AVG Volume (30 Days)
- USCB 11.7K
- SERA 67.0K
- Earning Date
- USCB 10-24-2024
- SERA 08-07-2024
- Dividend Yield
- USCB 1.39%
- SERA N/A
- EPS Growth
- USCB N/A
- SERA N/A
- EPS
- USCB 0.88
- SERA N/A
- Revenue
- USCB $66,705,000.00
- SERA $107,000.00
- Revenue This Year
- USCB N/A
- SERA N/A
- Revenue Next Year
- USCB $1.01
- SERA $2,020.00
- P/E Ratio
- USCB $16.31
- SERA N/A
- Revenue Growth
- USCB N/A
- SERA N/A
- 52 Week Low
- USCB $10.04
- SERA $1.52
- 52 Week High
- USCB $16.82
- SERA $12.36
- Technical
- Relative Strength Index (RSI)
- USCB 47.60
- SERA 49.79
- Support Level
- USCB $14.01
- SERA $6.86
- Resistance Level
- USCB $14.77
- SERA $7.47
- Average True Range (ATR)
- USCB 0.46
- SERA 0.42
- MACD
- USCB -0.07
- SERA 0.02
- Stochastic Oscillator
- USCB 41.53
- SERA 69.77
About USCB USCB Financial Holdings Inc.
USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.